A White House official who once led the oil industry's fight against limits on greenhouse gases has repeatedly edited government climate reports in ways that play down links between such emissions and global warming, according to internal documents.
In handwritten notes on drafts of several reports issued in 2002 and 2003, the official, Philip Cooney, removed or adjusted descriptions of climate research that government scientists and their supervisors, including some senior Bush administration officials, had already approved. In most cases, the changes appeared in the final reports.
The dozens of changes, while sometimes as subtle as the insertion of the phrase "significant and fundamental" before the word "uncertainties," tend to produce an air of doubt about findings that most climate experts say are robust.
Cooney is chief of staff for the White House Council on Environmental Quality, the office that helps devise and promote administration policies on environmental issues.
Before going to the White House in 2001, he was the "climate team leader" and a lobbyist at the American Petroleum Institute. A lawyer with a bachelor's degree in economics, he has no scientific training.
The documents were obtained by the New York Times from the Government Accountability Project, a nonprofit legal-assistance group for government whistle-blowers. The group is representing Rick Piltz, who resigned in March as a senior associate in the office that coordinates government climate research.
A White House spokeswoman, Michele St. Martin, said Tuesday that Cooney would not be made available to comment because he was not cleared as a spokesman.
Other White House officials said the changes made by Cooney were part of the normal interagency review that takes place on all documents related to global environmental change. Cooney's alterations are sometimes as simple as the insertion of an adjective, but they cause clear shifts in the meaning of the documents.
Meanwhile, President George W. Bush's decision not to sign the US up to the Kyoto global warming treaty was partly a result of pressure from ExxonMobil, the world's most powerful oil company, and other industries, according to US State Department papers seen by the Guardian.
The documents reinforce widely-held suspicions of how close the company is to the administration and its role in helping to formulate US policy.
In briefing papers given before meetings to the US under-secretary of state, Paula Dobriansky, between 2001 and last year, the administration is found thanking Exxon executives for the company's "active involvement" in helping to determine climate change policy, and also seeking its advice on what climate change policies the company might find acceptable.
Other papers suggest that Dobriansky should sound out Exxon executives and other anti-Kyoto business groups on potential alternatives to Kyoto.
Until now Exxon has publicly maintained that it had no involvement in the US' rejection of Kyoto.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very